View Author
dai: 069317003
scopus: 35242863900

Krenning, E.P.

(Eric Krenning)

Supervisor (promotor) of 12 dissertations


patient tumor study uptake somatostatin treatment receptor therapy liver imaging hormone neuroendocrine effect disease tumours peptide thyroid carcinoid result cancer analogue kidney tumour transport metastase activity response tissue neuroendocrine tumors octreotide radionuclide krenning serum group level analog liver metastases krenning ep jong m concentration month medicine survival radioactivity table scintigraphy journal 177 lu-octreotate lu-dota control metastatic binding system plasma membrane growth library erasmus mc in-dtpa children lu-octreotate injection bakker wh protein value radiolabeled radiation oocyte kwekkeboom radiolabelled carcinoma surgery lesion thyroid hormone cycle transporter toxicity syndrome incubation radiolabelled somatostatin analogues department




10 Most Recent Publications

Peptide receptor radionuclide therapy (PRRT) for GEP-NETs (Article)
Bergsma, H. Vliet, E.I. van Teunissen, J.J.M. Kam, B.L. Herder, W.W. de Peeters, R.P. Krenning, E.P. Kwekkeboom, D.
2012-12-01
Tumor response assessment to treatment with [ 177Lu-DOTA 0,Tyr 3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: Differential response of bone versus soft-tissue lesions (Article)
Vliet, E.I. van Hermans, J.J. Ridder, M.A.J. de Teunissen, J.J.M. Kam, B.L. Krijger, R.R. de Krenning, E.P. Kwekkeboom, D.
2012-09-01
Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy (Article)
Vliet, E.I. van Teunissen, J.J.M. Kam, B.L. Jong, M. de Krenning, E.P. Kwekkeboom, D.
2012-01-10
Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy (Article)
Schaik, E. van Vliet, E.I. van Herder, W.W. de Feelders, R.A. Krenning, E.P. Khan, S. Kamp, K. Valkema, R. Nederveen, F.H. van Teunissen, J.J.M. Kwekkeboom, D.J.
2011-11-01
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours (Article)
Teunissen, J.J.M. Kwekkeboom, D.J. Valkema, R. Krenning, E.P.
2011-10-01
Quality of life in 265 patients with gastroenteropancreatic or bronchial neuroendocrine tumors treated with [ 177Lu-DOTA 0,Tyr 3]octreotate (Article)
Khan, S. Krenning, E.P. Essen, M. van Kam, B.L. Teunissen, J.J.M. Kwekkeboom, D.J.
2011-09-01
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts (Article)
Schroeder, R.P.J. Weerden, W.M. van Jong, M. de Krenning, E.P. Bangma, C.H. Berndsen, S.C. Grievink-De Ligt, C.H. Groen, H.C. Reneman, S. Blois, E. de Breeman, W.A.P.
2011-07-01
68Ga-labeled DOTA-peptides and 68Ga-labeled radiopharmaceuticals for positron emission tomography: Current status of research, clinical applications, and future Perspectives (Article)
Breeman, W.A.P. Blois, E. de Sze Chan, H. Konijnenberg, M. Kwekkeboom, D.J. Krenning, E.P.
2011-07-01
The relation between 25-hydroxyvitamin D with peak bone mineral density and body composition in healthy young adults (Article)
Boot, A.M. Krenning, E.P. Muinck Keizer-Schrama, S.M.P.F. de
2011-06-01
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging? (Article)
Walrand, S. Flux, G. Konijnenberg, M. Valkema, R. Krenning, E.P. Lhommel, R. Pauwels, S. Jamar, F.
2011-05-01
  • rss icon RSS Publication Feed
  • foaf icon FOAF Profile